Retatrutide 2026: Availability Timeline, Trials & What We Know
Retatrutide 2026: FDA approval timeline, clinical trial results, weight loss data, and comparison to semaglutide and tirzepatide.
Get compounded GLP-1 medication prescribed online
Affordable, doctor-backed access to compounded semaglutide and tirzepatide. Complete a free online consultation with a US-licensed provider. If approved, medication is shipped to your door in 3-5 business days.
See if I qualify — Free consultationAvailable online · Shipped to your door anywhere in the US
Paid partnership · Prescription product requiring a physician consultation · Not everyone qualifies · Results vary
Available online. Shipped directly to your door anywhere in the US.
Key Takeaways
- Retatrutide is a triple agonist (GLP-1 + GIP + glucagon) — first of its kind
- Phase 2 results: up to 24.2% weight loss at 48 weeks — more than any current GLP-1
- FDA approval expected late 2026 or early 2027 (Phase 3 TRIUMPH trials ongoing)
- Already 4% of Reddit GLP-1 mentions — consumer demand is ahead of regulatory timeline
- Manufactured by Eli Lilly — same company as Zepbound/Mounjaro
What is retatrutide?
Retatrutide is an investigational weight loss medication developed by Eli Lilly. It is the first triple receptor agonist — activating GLP-1, GIP, and glucagon receptors simultaneously. This triple mechanism may produce more weight loss than any currently available GLP-1 medication.
Can't wait for retatrutide? Start with available GLP-1s now.
Compounded semaglutide from $147/month, tirzepatide from $249/month. Free online consultation. No insurance needed.
See if I qualify — Free consultationFrom $147/month · No insurance needed · Ships nationwide in 3-5 days · Paid partnership · Results vary
How retatrutide compares to existing GLP-1s
| Medication | Receptors activated | Weight loss | Status |
|---|---|---|---|
| Semaglutide (Wegovy/Ozempic) | GLP-1 | ~15% | FDA-approved |
| Tirzepatide (Zepbound/Mounjaro) | GLP-1 + GIP | ~20-22% | FDA-approved |
| Retatrutide | GLP-1 + GIP + Glucagon | ~24.2% (Phase 2) | Phase 3 trials |
Phase 2 trial results
The Phase 2 trial of retatrutide showed impressive results:
- 12mg dose: 24.2% weight loss at 48 weeks
- 8mg dose: 22.9% weight loss at 48 weeks
- 4mg dose: 17.3% weight loss at 48 weeks
- Most common side effects: nausea, diarrhea, vomiting (similar to other GLP-1s)
- Greater reduction in waist circumference than semaglutide or tirzepatide
FDA approval timeline
| Phase | Status | Timeline |
|---|---|---|
| Phase 2 | Complete | Published 2023 |
| Phase 3 (TRIUMPH trials) | Ongoing | Expected completion: 2026 |
| FDA submission | Pending | Late 2026 (estimated) |
| FDA approval | Pending | Late 2026 - early 2027 (estimated) |
| Market availability | Pending | 2027 (estimated) |
Why retatrutide matters
Retatrutide's triple agonist mechanism offers potential advantages over current GLP-1s:
- More weight loss: ~24% vs ~15-22% for current medications
- Glucagon activation: May increase fat burning and energy expenditure
- Cardiovascular benefits: Glucagon receptor activation may improve lipid profiles
- For non-responders: Patients who don't respond to semaglutide or tirzepatide may respond to retatrutide's different mechanism
What to do while waiting for retatrutide
If you are interested in retatrutide but waiting for FDA approval, you can start your weight loss journey now with available GLP-1 medications:
- Compounded semaglutide: From $147/month — proven ~15% weight loss
- Compounded tirzepatide: From $249/month — ~20-22% weight loss
- Start treatment now, and switch to retatrutide when it becomes available
- Develop healthy habits during treatment that will support long-term success
Check your eligibility for currently available GLP-1 medications.
Frequently asked questions
Can I get retatrutide now?
No. Retatrutide is not yet FDA-approved and is only available through clinical trials. Be cautious of any provider claiming to sell retatrutide — it is not legally available outside of trials. For more, read our emerging GLP-1 guide.
Will retatrutide be available as a compounded medication?
It is too early to say. Compounded versions would only be possible if there is an FDA-declared shortage after approval. Given Eli Lilly's manufacturing capacity, a shortage is less likely than with Wegovy.
Conclusion
Retatrutide represents the next generation of GLP-1 weight loss medications, with Phase 2 data showing ~24% weight loss — more than any currently available option. While FDA approval is expected in late 2026 or early 2027, patients can start their weight loss journey now with compounded semaglutide or tirzepatide and switch to retatrutide when it becomes available.
Ready to start? Check your eligibility for currently available GLP-1 medications today.
Affiliate disclosure: This article contains affiliate links. We may earn a commission if you sign up through them, at no extra cost to you. This is a paid partnership. Compounded GLP-1 medications are prescription products requiring a physician consultation — not everyone qualifies, and results vary. Medical disclaimer: This content is for informational purposes only and is not medical advice. Retatrutide is investigational and not FDA-approved.
Related GLP-1 guides
Doctor-backed GLP-1 weight loss from $147/month
Compounded semaglutide & tirzepatide. Online consultation with a US-licensed provider. No insurance needed.
Paid partnership · Prescription product · Not everyone qualifies · Results vary
Real patients. Real results.
Join 50,000+ patients who transformed their lives with GLP-1 medications
"I tried everything — keto, intermittent fasting, gym memberships. Nothing worked long-term. GLP-1 changed everything. I lost 47 pounds in 8 months and finally feel like myself again. The online process was so easy — I had my prescription in 2 days."
Jessica M., 38
Texas
-47 lbs
in 8 months
Compounded semaglutide
"At 52, my doctor said I was heading toward diabetes. I started tirzepatide through a telehealth program and lost 62 pounds. My A1C is back to normal, my blood pressure dropped, and I'm off two medications. Wish I'd done this years ago."
David R., 52
Florida
-62 lbs
in 11 months
Tirzepatide (Zepbound)
"I was skeptical about doing this online, but the whole process was professional and easy. My provider answered all my questions, and the medication arrived in 4 days. I've lost 38 pounds and finally have energy to play with my kids again."
Aisha K., 34
California
-38 lbs
in 6 months
Compounded semaglutide
Results vary. These testimonials reflect individual experiences and are not typical. Weight loss depends on diet, activity, and adherence to medication.
How it works — 3 simple steps
Take the 60-second quiz
Answer a few questions about your health, weight goals, and medical history. It's free and confidential.
1 min
Meet your US-licensed provider
A board-certified clinician reviews your profile and prescribes the right GLP-1 medication for you — entirely online.
24-48 hrs
Get medication shipped to your door
Your prescription is filled by a US pharmacy and delivered in discreet packaging in 3-5 business days.
3-5 days
Get GLP-1 savings alerts & weekly tips
Join 50,000+ readers. Price drops, new coupons, and expert weight-loss advice — delivered weekly. Unsubscribe anytime.
Free. No spam. Unsubscribe anytime.